US 12396991
Biomarkers for the diagnosis and treatment of fibrotic lung disease
granted A61KA61K31/197A61K31/198
Quick answer
US patent 12396991 (Biomarkers for the diagnosis and treatment of fibrotic lung disease) held by The Regents of the University of Colorado, a Body Corporate expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/197, A61K31/198, A61K31/4412, A61K31/4418